Predictors of Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae (CRE) among Patients with Known CRE Carriage at Their Next Hospital Encounter

被引:57
作者
Schechner, Vered [1 ]
Kotlovsky, Tali [1 ]
Tarabeia, Jalal [1 ]
Kazma, Meital [1 ]
Schwartz, David [2 ]
Navon-Venezia, Shiri [1 ]
Carmeli, Yehuda [1 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Clin Microbiol Lab, IL-64239 Tel Aviv, Israel
关键词
KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK-FACTORS; BETA-LACTAMASES; K; PNEUMONIAE; INFECTION; OUTBREAK; SPREAD; EPIDEMIOLOGY; ACQUISITION;
D O I
10.1086/659762
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND. Carbapenem-resistant Enterobacteriaceae (CRE) are important extremely drug-resistant pathogens that have emerged during the past decade. Early identification and isolation of carriers are key components of an effective infection control strategy in healthcare facilities. Very little is known about the natural history of CRE carriage. We aimed to determine the predictors of a positive CRE rectal screen test among patients with known CRE carriage screened at their next hospital encounter. METHODS. A case-control study was conducted. Sixty-six patients who tested positive for CRE carriage were surveyed for CRE rectal carriage at the next hospital encounter; screen-positive patients were compared with screen-negative control patients. Data were extracted from the patients' medical records and from the hospital computerized database. RESULTS. Twenty-three case patients and 43 control patients were identified. Predictors for a positive CRE rectal carriage test were (1) prior fluoroquinolone use (odds ratio [OR], 4.27; 95% confidence interval [CI], 1.10-16.6), (2) admission from an institution or another hospital (OR, 4.04; 95% CI, 1.33-12.37), and (3) time interval less than or equal to 3 months since the first positive CRE test (OR, 3.59; 95% CI, 1.24-10.37). Among patients with no predictor variables, the likelihood of having a positive screen test at the next hospital encounter was. If they had at least 1 predictor, 1/7 the likelihood increased to 1/2. CONCLUSIONS. Prior fluoroquinolone use, transfer from another healthcare facility, and admission less than or equal to 3 months since the first CRE isolation are predictors of persistent CRE rectal carriage. These predictors can be used in designing CRE prevention strategies. Infect Control Hosp Epidemiol 2011;32(5):497-503
引用
收藏
页码:497 / 503
页数:7
相关论文
共 38 条
  • [11] Funuro JP, 2008, AM J INFECT CONTROL, V36, P468, DOI [10.1016/j.ajic:2008.01.003, 10.1016/j.ajic.2008.01.003]
  • [12] Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
    Gasink, Leanne B.
    Edelstein, Paul H.
    Lautenbach, Ebbing
    Synnestvedt, Marie
    Fishman, Neil O.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (12) : 1180 - 1185
  • [13] Transfer of Carbapenem-Resistant Plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in Patient
    Goren, Moran G.
    Carmeli, Yehuda
    Schwaber, Mitchell J.
    Chmelnitsky, Inna
    Schechner, Vered
    Navon-Venezia, Shiri
    [J]. EMERGING INFECTIOUS DISEASES, 2010, 16 (06) : 1014 - 1017
  • [14] Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008
    Goren, Moran G.
    Navon-Venezia, Shiri
    Chmelnitsky, Inna
    Carmeli, Yehuda
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2687 - 2691
  • [15] Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Puerto Rico Associated with a Novel Carbapenemase Variant
    Gregory, Christopher J.
    Llata, Eloisa
    Stine, Nicholas
    Gould, Carolyn
    Santiago, Luis Manuel
    Vazquez, Guillermo J.
    Robledo, Iraida E.
    Srinivasan, Arjun
    Goering, Richard V.
    Tomashek, Kay M.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) : 476 - 484
  • [16] Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
    Kitchel, Brandon
    Rasheed, J. Kamile
    Patel, Jean B.
    Srinivasan, Arjun
    Navon-Venezia, Shiri
    Carmeli, Yehuda
    Brolund, Alma
    Giske, Christian G.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3365 - 3370
  • [17] Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae
    Kochar, Sandeep
    Sheard, Timothy
    Sharma, Roopali
    Hui, Alan
    Tolentino, Elaine
    Allen, George
    Landman, David
    Bratu, Simona
    Augenbraun, Michael
    Quale, John
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (05) : 447 - 452
  • [18] Korten V, 1993, Drugs, V45 Suppl 3, P125
  • [19] Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
    Kwak, YG
    Choi, SH
    Choo, EJ
    Chung, JW
    Jeong, JY
    Kim, NJ
    Woo, JH
    Ryu, J
    Kim, YS
    [J]. MICROBIAL DRUG RESISTANCE, 2005, 11 (02) : 165 - 169
  • [20] Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    Lautenbach, E
    Strom, BL
    Bilker, WB
    Patel, JB
    Edelstein, PH
    Fishman, NO
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1288 - 1294